Lista de obras -

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

artículo científico publicado en 2002

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

artículo científico publicado en 2003

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

artículo científico publicado en 2000

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

artículo científico publicado en 2017

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

artículo científico publicado en 2005

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

artículo científico publicado en 2002

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

artículo científico publicado en 2002

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

artículo científico publicado en 2003

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

artículo científico publicado en 2005

A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patients.

artículo científico publicado en 2008

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

artículo científico publicado en 2020

Analyzing the "correct" endpoint

artículo científico publicado en 2006

Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

artículo científico publicado en 2019

Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1

artículo científico publicado en 2013

Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.

artículo científico publicado en 2012

Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial

artículo científico publicado en 2015

Cancer Caregiver: Perceived Benefits of Technology

artículo científico publicado en 2015

Cancer caregiver quality of life: need for targeted intervention

artículo científico

Caregivers of patients with cancer fatigue: a high level of symptom burden

artículo científico publicado en 2013

Combining information across symptom studies

artículo científico publicado en 2005

Combining symptom and survival data

artículo científico publicado en 2006

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

artículo científico publicado en 2002

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

artículo científico publicado en 2010

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial

article

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

artículo científico publicado en 2006

Do age and quality of life of patients with cancer influence quality of life of the caregiver?

artículo científico publicado en 2014

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

artículo científico publicado en 2013

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)

artículo científico publicado en 2007

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy

artículo científico publicado en 2019

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy - CORRIGENDUM

artículo científico publicado en 2019

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.

artículo científico publicado en 2017

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

artículo científico publicado en 2017

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

artículo científico publicado en 2017

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

artículo científico publicado en 2010

Health related quality of life in patients with Charcot arthropathy of the foot and ankle

artículo científico publicado en 2007

Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer

artículo científico publicado en 2013

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial

artículo científico publicado en 2006

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

artículo científico publicado en 2001

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

artículo científico publicado en 2020

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254

artículo científico publicado en 2016

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

artículo científico publicado en 2015

Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study

artículo científico publicado en 2010

Measuring spiritual quality of life in patients with cancer.

artículo científico publicado en 2007

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

artículo científico publicado en 2010

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

artículo científico publicado en 2015

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study

artículo científico publicado en 2014

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

artículo científico publicado en 2014

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

artículo científico publicado en 2009

Overall survival and self-reported fatigue in patients with esophageal cancer

artículo científico publicado en 2012

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).

artículo científico publicado en 2016

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

scientific article published on 16 July 2020

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma ⬇️

artículo científico publicado el 1 de enero de 2002

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

artículo científico publicado en 2018

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.

artículo científico publicado en 2005

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

scientific article published on 01 March 2000

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

artículo científico publicado en 2003

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia

artículo científico publicado en 2005

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

scientific article published on 01 April 2000

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

artículo científico publicado en 2001

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

artículo científico publicado en 2005

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

artículo científico publicado en 2001

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

artículo científico publicado en 2010

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

artículo científico publicado en 2001

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

artículo científico publicado en 2005

Phase II Evaluation of Desipramine for the Treatment of Hot Flashes

artículo científico publicado en 2007

Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

artículo científico publicado en 2015

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

scientific article published on 02 December 2013

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

artículo científico publicado en 2008

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA

artículo científico publicado en 2008

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

artículo científico publicado en 2010

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

artículo científico publicado en 2010

Pilot evaluation of aprepitant for the treatment of hot flashes

artículo científico publicado en 2006

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. ⬇️

artículo científico publicado en 2009

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

artículo científico publicado en 2002

Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

artículo científico publicado en 2010

Quality of life of caregivers of patients with advanced-stage cancer

artículo científico publicado en 2006

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

artículo científico publicado en 2012

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

artículo científico publicado en 2007

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

artículo científico publicado en 2016

Rising importance of patient-reported outcomes

artículo científico publicado en 2006

Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary intervention

artículo científico publicado en 2007

Spiritual quality of life in advanced cancer patients receiving radiation therapy

artículo científico publicado en 2013

Spiritual well-being and quality of life of women with ovarian cancer and their spouses

artículo científico publicado en 2011

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).

artículo científico publicado en 2017

The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

artículo científico publicado en 2015

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

artículo científico publicado en 2007

The relation between cancer patient treatment decision-making roles and quality of life

artículo científico publicado en 2013

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).

artículo científico publicado en 2011

Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being

artículo científico publicado en 2010

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).

artículo científico publicado en 2011

Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?

artículo científico publicado en 2006

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy

artículo científico publicado en 2010

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up

artículo científico publicado en 2015

Lista de obras de

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

A prospective descriptive study exploring hope, spiritual well-being, and quality of life in hospitalized patients.

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

Analyzing the "correct" endpoint

Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1

Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.

Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial

Cancer Caregiver: Perceived Benefits of Technology

Cancer caregiver quality of life: need for targeted intervention

Caregivers of patients with cancer fatigue: a high level of symptom burden

Combining information across symptom studies

Combining symptom and survival data

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial

Dehydroepiandrosterone for the treatment of hot flashes: a pilot study

Do age and quality of life of patients with cancer influence quality of life of the caregiver?

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy

Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy - CORRIGENDUM

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer.

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

Health related quality of life in patients with Charcot arthropathy of the foot and ankle

Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study

Measuring spiritual quality of life in patients with cancer.

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

Overall survival and self-reported fatigue in patients with esophageal cancer

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma ⬇️

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas

Phase II Evaluation of Desipramine for the Treatment of Hot Flashes

Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

Pilot evaluation of aprepitant for the treatment of hot flashes

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. ⬇️

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

Quality of life of caregivers of patients with advanced-stage cancer

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).